Par Drugs Faces Intense Selling Pressure Amidst Significant Price Declines and Losses

Par Drugs & Chemicals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 5.00% in just one day, starkly contrasting with the Sensex's minor drop of 0.33%. Over the past week, Par Drugs has plummeted by 22.37%, while the Sensex has only decreased by 0.59%.
The stock's performance over the past month reveals a staggering decline of 34.31%, compared to the Sensex's 1.80% drop. In the last three months, Par Drugs has lost 55.75%, significantly underperforming the Sensex, which has seen a decline of just 2.44%. Year-to-date, the stock is down 35.63%, while the Sensex has fallen by 3.14%.

Today, Par Drugs hit a new 52-week low of Rs. 128.04 and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This persistent selling pressure may be attributed to various factors, including market sentiment and sector-specific challenges, leading to a pronounced underperformance relative to the broader market.